Literature DB >> 8568262

The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites.

A Mey1, H Leffler, Z Hmama, G Normier, J P Revillard.   

Abstract

Galectin-3 is a beta-galactoside binding protein expressed by activated macrophages, epithelial cells, and certain other cell types. Galectin-3 has a C-terminal carbohydrate binding domain, an N-terminal part consisting of a proline- and glycine-rich repetitive domain, and a small N-terminal domain. Two independent LPS binding sites on galectin-3 were demonstrated by binding of biotinylated LPS to immobilized recombinant galectin-3. One appears to be the carbohydrate binding site in the C-terminal domain that confers binding of LPS from Klebsiella pneumoniae that has a beta-galactoside-containing polysaccharide chain. This binding is best demonstrated using galectin-3 immunocaptured by a mAb to the N-terminal part (M3/38) and is inhibited by lactose. In contrast, Salmonella minnesota R7 LPS (Rd mutant), which is devoid of beta-galactosides, appears to bind to a site within the N-terminal part of galectin-3. This interaction is best demonstrated using galectin-3 directly immobilized in wells, and it is inhibited by the Ab M3/38, but not by lactose. Binding inhibition by polymyxin B and the profile of inhibition by a panel of LPSs with different amounts of the inner and outer cores present indicate that this second binding site recognizes the lipid A/inner core region of LPSs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568262

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

Review 1.  Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Authors:  Sachiko Sato; Julie Nieminen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 2.  Insect galectins: roles in immunity and development.

Authors:  Karen E Pace; Linda G Baum
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

3.  Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR.

Authors:  Hans Ippel; Michelle C Miller; Sabine Vértesy; Yi Zheng; F Javier Cañada; Dennis Suylen; Kimiko Umemoto; Cecilia Romanò; Tilman Hackeng; Guihua Tai; Hakon Leffler; Jürgen Kopitz; Sabine André; Dieter Kübler; Jesús Jiménez-Barbero; Stefan Oscarson; Hans-Joachim Gabius; Kevin H Mayo
Journal:  Glycobiology       Date:  2016-02-23       Impact factor: 4.313

4.  Detection of galectin-3 interaction with commensal bacteria.

Authors:  Devon Kavanaugh; Marian Kane; Lokesh Joshi; Rita M Hickey
Journal:  Appl Environ Microbiol       Date:  2013-03-22       Impact factor: 4.792

Review 5.  Key regulators of galectin-glycan interactions.

Authors:  Nourine A Kamili; Connie M Arthur; Christian Gerner-Smidt; Eden Tafesse; Anna Blenda; Marcelo Dias-Baruffi; Sean R Stowell
Journal:  Proteomics       Date:  2016-12       Impact factor: 3.984

6.  Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins.

Authors:  S K Gupta; S Masinick; M Garrett; L D Hazlett
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  LPS targets host guanylate-binding proteins to the bacterial outer membrane for non-canonical inflammasome activation.

Authors:  José Carlos Santos; Mathias S Dick; Brice Lagrange; Daniel Degrandi; Klaus Pfeffer; Masahiro Yamamoto; Etienne Meunier; Pawel Pelczar; Thomas Henry; Petr Broz
Journal:  EMBO J       Date:  2018-02-19       Impact factor: 11.598

Review 8.  Recognition of microbial glycans by soluble human lectins.

Authors:  Darryl A Wesener; Amanda Dugan; Laura L Kiessling
Journal:  Curr Opin Struct Biol       Date:  2017-05-05       Impact factor: 6.809

Review 9.  Roles of galectins in infection.

Authors:  Gerardo R Vasta
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

10.  Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.

Authors:  Maurice Nachtigal; Abdul Ghaffar; Eugene P Mayer
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.